Indiomin MB and Alcohol/Food Interactions
There are 3 alcohol/food/lifestyle interactions with Indiomin MB (hyoscyamine / methenamine / methylene blue / sodium biphosphate).
Hyoscyamine Alcohol (Ethanol)
Moderate Drug Interaction
GENERALLY AVOID: Use of anticholinergic agents with alcohol may result in sufficient impairment of attention so as to render driving and operating machinery more hazardous. In addition, the potential for abuse may be increased with the combination. The mechanism of interaction is not established but may involve additive depressant effects on the central nervous system. No effect of oral propantheline or atropine on blood alcohol levels was observed in healthy volunteers when administered before ingestion of a standard ethanol load. However, one study found impairment of attention in subjects given atropine 0.5 mg or glycopyrrolate 1 mg in combination with alcohol.
MANAGEMENT: Alcohol should generally be avoided during therapy with anticholinergic agents. Patients should be counseled to avoid activities requiring mental alertness until they know how these agents affect them.
References (1)
- Linnoila M (1973) "Drug effects on psychomotor skills related to driving: interaction of atropine, glycopyrrhonium and alcohol." Eur J Clin Pharmacol, 6, p. 107-12
Sodium Biphosphate Food
Moderate Food Interaction
ADJUST DOSING INTERVAL: Bowel cleansing products can increase the gastrointestinal transit rate. Oral medications administered within one hour of the start of administration of the bowel cleansing solution may be flushed from the gastrointestinal tract and not properly absorbed.
MANAGEMENT: Patients should be advised that absorption of oral medications may be impaired during bowel cleansing treatment. Oral medications (e.g., anticonvulsants, oral contraceptives, antidiabetic agents, antibiotics) should not be administered during and within one hour of starting bowel cleansing treatment whenever possible. However, if concomitant use cannot be avoided, monitoring for reduced therapeutic effects may be advisable.
References (2)
- "Product Information. Golytely (polyethylene glycol 3350 with electrolytes)." Braintree
- (2022) "Product Information. Prepopik (citric acid/Mg oxide/Na picosulfate)." Ferring Pharmaceuticals Inc
Switch to consumer interaction data
Hyoscyamine High Blood Pressure (Hypertension)
Minor Potential Hazard, Low plausibility
anticholinergics - hypertension
Cardiovascular effects of anticholinergics may exacerbate hypertension. Therapy with anticholinergic agents should be administered cautiously in patients with hypertension.
References (7)
- (2002) "Product Information. Benadryl (diphenhydramine)." Parke-Davis
- (2001) "Product Information. Antivert (meclizine)." Roerig Division
- (2001) "Product Information. Marezine (cyclizine)." Glaxo Wellcome
- Valentin N, Staffeldt H, Kyst A (1984) "Effect of i.v. atropine on cardiac rhythm, heart rate, blood pressure and airway secretion during isoflurane anaesthesia." Acta Anaesthesiol Scand, 28, p. 621-4
- (2022) "Product Information. Atropine Sulfate (atropine)." ESI Lederle Generics
- (2001) "Product Information. Artane (trihexyphenidyl)." Lederle Laboratories
- (2002) "Product Information. Atropisol (atropine ophthalmic)." Ciba Vision Ophthalmics
Switch to consumer interaction data
Indiomin MB drug interactions
There are 653 drug interactions with Indiomin MB (hyoscyamine / methenamine / methylene blue / sodium biphosphate).
Indiomin MB disease interactions
There are 29 disease interactions with Indiomin MB (hyoscyamine / methenamine / methylene blue / sodium biphosphate) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- inflammatory bowel disease
- intestinal obstruction disorders
- crystalluria
- gout
- liver disease
- methemoglobinemia in G-6-PD
- hypocalcemia
- phosphate imbalance
- electrolyte imbalance
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- renal dysfunction
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Indiomin MB (hyoscyamine / methenamine / methylene blue / sodium biphosphate)
- Indiomin MB consumer information
- Check interactions
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- Drug class: urinary antispasmodics
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Augmentin
Augmentin is a prescription antibiotic combining amoxicillin and clavulanate to treat bacterial ...
Bactrim
Bactrim (sulfamethoxazole and trimethoprim) is an antibiotic used to treat ear infections, urinary ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Sulfamethoxazole/trimethoprim
Sulfamethoxazole/trimethoprim systemic is used for acne, bacterial infection, bacterial skin ...
Nitrofurantoin
Nitrofurantoin is an antibiotic used to treat urinary tract infections. Learn about side effects ...
Amoxicillin/clavulanate
Amoxicillin and clavulanate potassium is a combination antibiotic used to treat bacterial ...
Levofloxacin
Levofloxacin is a fluoroquinolone antibiotic used to treat serious bacterial infections and prevent ...
Ceftriaxone
Ceftriaxone systemic is used for bacteremia, bacterial endocarditis prevention, bacterial ...
Ciprofloxacin
Ciprofloxacin is an antibiotic belong to a group of drugs called fluoroquinolones. Learn about side ...
Doxycycline
Doxycycline is a tetracycline antibiotic used to treat many different bacterial infections such as ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.